Tilray Reports Positive Results For Medical Marijuana In Chemotherapy Patients

New research indicates that marijuana could alleviate some of the worst effects experienced by cancer patients undergoing chemotherapy. Tilray (NASDAQ:TLRY) announced Monday that a clinical trial in Australia has demonstrated positive results in reducing the nausea and vomiting common to people enduring such treatments for their illness.

The phase 2 study comprised 81 patients, who were dosed three times per day with capsules of either marijuana supplied by Tilray or a placebo, according to an entry in the Annals of Oncology. This was accompanied by dosing with antiemetics, i.e. medications that suppress nausea and vomiting. The researchers found “significant improvement” in the control of those reactions.

Tilray specified that a quarter of the study’s participants taking the marijuana experienced no vomiting or nausea at all, against 14% of those who were administered the placebo.

There were, however, side effects such as dizziness and drowsiness, which were reported in around one-third of the patients. These participants demonstrated moderate to severe forms of these effects, but Tilray said the study’s researchers consider these to be manageable. [Read more at International Business Times]

The post Tilray Reports Positive Results For Medical Marijuana In Chemotherapy Patients appeared first on Cannabis Business Executive – Cannabis and Marijuana industry news.

Leave a Reply